Fig. 3.
NAC prevents EMT in both an AEC line (RLE-6TN) and primary AEC. A: NAC prevents TGF-β1-induced increases in the mesenchymal marker vimentin in both RLE-6TN cells (black bars) and primary AEC (gray bars). B: NAC also prevents TGF-β1-induced increases in the myofibroblast marker α-SMA in both RLE-6TN cells (black bars) and primary AEC (gray bars). *Significantly different from TGF-β1. †Significantly different from control. N = 3–5.